Core Laboratories Inc. (CLB) stock
CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3010% above fair value
$9.11+0.10 (+1.11%)
Close on Nov 13, 2026Market cap $417.45MP/E 26.8Yield 0.44%
Core Laboratories price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Core Laboratories's price to sales ratio was 0.8× on Nov 11, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 0.8× to 3.1×, with a median of 1.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.8× | −0.6 |
| 2025 | Dec 31, 2025 | 1.4× | −0.1 |
| 2024 | Dec 31, 2024 | 1.6× | −0.1 |
| 2023 | Dec 29, 2023 | 1.6× | −0.4 |
| 2022 | Dec 30, 2022 | 2.0× | – |
See a number that looks wrong?